Cangrelor Neonatal PK/PD and Safety Study
NCT02765633
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Partial Obstruction of Systemic to Pulmonary Artery Shunt
Complete Obstruction of Systemic to Pulmonary Artery Shunt
Interventions
DRUG:
Cangrelor
Sponsor
Chiesi Farmaceutici S.p.A.